# The Relationship Between Dietary Sodium Intake and Cognitive Function: A Narrative Review

**Authors:** Samantha L Gardener, M Fu, L Morini, T Schwartzkopff, G Savage, RN Martins, SR Rainey-Smith

PMC · DOI: 10.1007/s13668-026-00750-8 · 2026-03-21

## TL;DR

This review explores how high sodium intake may affect cognitive function, suggesting it could harm brain health in older individuals.

## Contribution

The paper synthesizes current evidence and highlights the need for better human studies on sodium and cognition.

## Key findings

- High sodium intake is linked to cognitive impairment and Aβ-amyloid aggregation in animal studies.
- Human studies show mixed results, making the relationship between sodium and cognition unclear.
- Using 24-hour urinary sodium measurements could improve future research accuracy.

## Abstract

This narrative review provides discussion on current evidence regarding the relationship between sodium intake and cognitive function in animal and human studies, as well as potential mechanisms underlying this relationship.

Recent evidence suggests high sodium intake is associated with development of cognitive impairment and neural dysfunction. Additionally, studies have proposed that high sodium intake is associated with increased aggregation of Aβ-amyloid and that hypertension (for which high sodium intake is a risk factor) modulates the relationship between Aβ-amyloid and development of cognitive impairment and Alzheimer’s disease. However, while animal studies demonstrate a consistent relationship between high sodium intake and cognitive impairment, this relationship remains less clear in humans.

Overall, mixed results were observed regarding whether sodium intake is associated with cognitive function. To a certain extent, the findings from this review support the notion that high sodium intake could be having a negative impact on middle and older-aged individuals’ cognitive health. Further exploration of the relationship between dietary sodium intake and cognition is needed in well characterised human cohorts, using comprehensive assessment of cognitive function. Furthermore, given self-report sodium intake can give over- or under-reported levels, the addition of 24-hour urinary sodium levels would enhance research findings and its interpretation.

The online version contains supplementary material available at 10.1007/s13668-026-00750-8.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Genes:** SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Glo1 (glyoxalase 1) [NCBI Gene 294320], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, Syn1 (synapsin I) [NCBI Gene 20964] {aka Syn-1, Syn1-S}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818] {aka CAMK, CAMK-II, CAMKG, MRD59}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 81646] {aka Creb}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Syp (synaptophysin) [NCBI Gene 20977] {aka A230093K24Rik, Syn, p38}, PTGER1 (prostaglandin E receptor 1) [NCBI Gene 5731] {aka EP1}, SYN1 (synapsin I) [NCBI Gene 6853] {aka EPILX, EPILX1, MRX50, SYN1a, SYN1b, SYNI}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CAT (catalase) [NCBI Gene 847], BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}
- **Diseases:** MCI (MESH:D060825), neural dysfunction (MESH:D015441), depression (MESH:D003866), CVD (MESH:D002318), synaptic dysfunction (MESH:C536122), behavioural impairments (MESH:D001523), Decreases in global cognitive function (MESH:D003072), PD (MESH:D010300), dendritic degeneration (MESH:D007635), Dementia (MESH:D003704), cerebral hypoperfusion (MESH:D002547), function (MESH:D003291), Hypertension (MESH:D006973), neurocognitive deficits (MESH:D009461), amyloid (MESH:C000718787), AD (MESH:D000544), cerebral amyloid angiopathy (MESH:D016657), anxiety (MESH:D001007), hippocampus-dependent memory deficits (MESH:D008569), neuronal death (MESH:D009410), inflammation (MESH:D007249)
- **Chemicals:** calcium (MESH:D002118), NO nitric oxide (MESH:D009569), ROS reactive oxygen species (-), cholesterol (MESH:D002784), nitrate (MESH:D009566), TCA (MESH:D014233), superoxide (MESH:D013481), potassium (MESH:D011188), Sodium (MESH:D012964), ROS (MESH:D017382), Salt (MESH:D012492), GSH (MESH:D005978), losartan (MESH:D019808), SCFAs (MESH:D005232), glucose (MESH:D005947), NaCl (MESH:D012965)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** N2a — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), /6 N — Mus musculus (Mouse), Transformed cell line (CVCL_D461), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

---
Source: https://tomesphere.com/paper/PMC13004737